Pantethine Alters Lipid Composition and Cholesterol Content of Membrane Rafts, With Down-Regulation of CXCL12-Induced T Cell Migration

Journal of Cellular Physiology

Volumn 230, Issue 10, 2015, Pages 2415-2425

  van Gijsel Bonnello, Manuel ^a   Acar, Niyazi ^b   Molino, Yves ^c   Bretillon, Lionel ^b   Khrestchatisky, Michel ^a   de Reggi, Max ^a   Gharib, Bouchra ^a  

^a Mediterranée University   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Vect Horus ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; PANTETHINE; STROMAL CELL DERIVED FACTOR 1; THIOL DERIVATIVE; CHOLESTEROL; LIPID; PANTETHEINE;

ACYLATION; ARTICLE; CELL ACTIVITY; CELL ADHESION; CELL SURFACE; CELLULAR DISTRIBUTION; CHEMOTAXIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; HUMAN; HUMAN CELL; JURKAT CELL LINE; LIPID COMPOSITION; LIPID MEMBRANE; LIPID RAFT; LYMPHOCYTE MIGRATION; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; LYMPHOCYTE ACTIVATION; METABOLISM; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; CHOLESTEROL; DOWN-REGULATION; HUMANS; JURKAT CELLS; LIPIDS; LYMPHOCYTE ACTIVATION; PANTETHEINE; RATS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84932603939     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24971     Document Type: Article

References (71)

1. Acar N, Berdeaux O, Gregoire S, Cabaret S, Martine L, Gain P, Thuret G, Creuzot-Garcher CP, Bron AM, Bretillon L. 2012. Lipid composition of the human eye: Are red blood cells a good mirror of retinal and optic nerve fatty acids. PLoS One 7:e35102.
2. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F. 1997. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186:139-146.
3. Bajenoff M, Granjeaud S, Guerder S. 2003. The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. J Exp Med 198:715-724.
4. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F. 2005. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280:35760-35766.
5. Berthiaume L, Resh MD. 1995. Biochemical characterization of a palmitoyl acyltransferase activity that palmitoylates myristoylated proteins. J Biol Chem 270:22399-22405.
6. Bocos C, Herrera E. 1998. Pantethine stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat. Environ Toxicol Pharmacol 6:59-66.
7. Bretillon L, Thuret G, Gregoire S, Acar N, Joffre C, Bron AM, Gain P, Creuzot-Garcher CP. 2008. Lipid and fatty acid profile of the retina, retinal pigment epithelium/choroid, and the lacrimal gland, and associations with adipose tissue fatty acids in human subjects. Exp Eye Res 87:521-528.
8. Brown DA, London E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221-17224.
9. Brunetti D, Dusi S, Giordano C, Lamperti C, Morbin M, Fugnanesi V, Marchet S, Fagiolari G, Sibon O, Moggio M, d'Amati G, Tiranti V. 2014. Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model. Brain 137:57-68.
10. Cappel RE, Gilbert HF. 1988. Thiol/disulfide exchange between 3-hydroxy-3-methylglutaryl-CoA reductase and glutathione. A thermodynamically facile dithiol oxidation. J Biol Chem 263:12204-12212.
11. Chaturvedi M, Molino Y, Sreedhar B, Khrestchatisky M, Kaczmarek L. 2014. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier. Int J Nanomedicine 9:575-588.
12. Cighetti G, Del Puppo M, Paroni R, Fiorica E, Galli Kienle. 1987. Pantethine inhibits cholesterol and fatty acid syntheses and stimulates carbon dioxide formation in isolated rat hepatocytes. J Lipid Res 28:152-161.
13. Cighetti G, Del Puppo M, Paroni R, Galli Kienle. 1988. Modulation of HMG-CoA reductase activity by pantetheine/pantethine. Biochim Biophys Acta 963:389-393.
14. Cornille E, Abou-Hamdan M, Khrestchatisky M, Nieoullon A, de Reggi M, Gharib B. 2010. Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury. BMC Neurosci 11:51.
15. Drisdel RC, Green WN. 2004. Labeling and quantifying sites of protein palmitoylation. Biotechniques 36:276-285.
16. Duchesneau P, Gallagher E, Walcheck B, Waddell TK. 2007. Up-regulation of leukocyte CXCR4 expression by sulfatide: An L-selectin-dependent pathway on CD4+ T cells. Eur J Immunol 37:2949-2960.
17. Dunphy JT, Greentree WK, Linder ME. 2001. Enrichment of G-protein palmitoyltransferase activity in low density membranes: In vitro reconstitution of Galphai to these domains requires palmitoyltransferase activity. J Biol Chem 276:43300-43304.
18. Dunzendorfer S, Rothbucher D, Schratzberger P, Reinisch N, Kahler CM, Wiedermann CJ. 1997. Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. Circ Res 81:963-969.
19. Falk W, Goodwin RH, Jr., Leonard EJ. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33:239-247.
20. Fourgeux C, Martine L, Pasquis B, Maire MA, Acar N, Creuzot-Garcher C, Bron A, Bretillon L. 2012. Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. Acta Ophthalmol 90:560-567.
21. Gensini GF, Prisco D, Rogasi PG, Matucci M, Neri Serneri. 1985. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment. Int J Clin Pharmacol Res 5:309-318.
22. Gerard C, Rollins BJ. 2001. Chemokines and disease. Nat Immunol 2:108-115.
23. Gilbert HF, Stewart MD. 1981. Inactivation of hydroxymethylglutaryl-CoA reductase from yeast by coenzyme A disulfide. J Biol Chem 256:1782-1785.
24. Gomez-Mouton C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jimenez-Baranda S, Illa I, Bernad A, Manes S, Martinez AC. 2001. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA 98:9642-9647.
25. Gomez-Mouton C, Lacalle RA, Mira E, Jimenez-Baranda S, Barber DF, Carrera AC, Martinez AC, Manes S. 2004. Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis. J Cell Biol 164:759-768.
26. Gouwy M, Struyf S, Berghmans N, Vanormelingen C, Schols D, Van Damme J. 2011. CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection. Eur J Immunol 41:963-973.
27. Greenwood J, Steinman L, Zamvil SS. 2006. Statin therapy and autoimmune disease: From protein prenylation to immunomodulation. Nat Rev Immunol 6:358-370.
28. Harder T. 2001. Raft membrane domains and immunoreceptor functions. Adv Immunol 77:45-92.
29. Hartmann TN, Grabovsky V, Pasvolsky R, Shulman Z, Buss EC, Spiegel A, Nagler A, Lapidot T, Thelen M, Alon R. 2008. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J Leukoc Biol 84:1130-1140.
30. Horejsi V, Drbal K, Cebecauer M, Cerny J, Brdicka T, Angelisova P, Stockinger H. 1999. GPI-microdomains: A role in signalling via immunoreceptors. Immunol Today 20:356-361.
31. Janes PW, Ley SC, Magee AI. 1999. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 147:447-461.
32. Kabouridis PS, Janzen J, Magee AL, Ley SC. 2000. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur J Immunol 30:954-963.
33. Kozak SL, Heard JM, Kabat D. 2002. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J Virol 76:1802-1815.
34. Le Y Honczarenko, Ho AM, Silberstein DK, 2005. CXC chemokine ligand 12-induced focal adhesion kinase activation and segregation into membrane domains is modulated by regulator of G protein signaling 1 in pro-B cells. J Immunol 174:2582-2590.
35. Lenne PF, Wawrezinieck L, Conchonaud F, Wurtz O, Boned A, Guo XJ, Rigneault H, He HT, Marguet D. 2006. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J 25:3245-3256.
36. Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD. 2010. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29:4599-4610.
37. Maher BM, Dhonnchu TN, Burke JP, Soo A, Wood AE, Watson RW. 2009. Statins alter neutrophil migration by modulating cellular Rho activity-a potential mechanism for statins-mediated pleotropic effects. J Leukoc Biol 85:186-193.
38. Manes S, del Real G, Lacalle RA, Lucas P, Gomez-Mouton C, Sanchez-Palomino S, Delgado R, Alcami J, Mira E, Martinez AC. 2000. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 1:190-196.
39. Manes S, Martinez AC. 2004. Cholesterol domains regulate the actin cytoskeleton at the leading edge of moving cells. Trends Cell Biol 14:275-278.
40. Merino JJ, Bellver-Landete V, Oset-Gasque MJ, Cubelos B. 2014. CXCR4/CXCR7 molecular involvement in neuronal and neural progenitor migration: Focus in CNS repair. J Cell Physiol 230:27-42.
41. Molino Y, Jabès F, Lacassagne E, Gaudin N, Khrestchatisky M. 2014. Setting up an in vitro model of rat blood-brain barrier (BBB): A focus on BBB impermeability and receptor-mediated transport. JoVE 88:e51278.
42. Mootz HD, Schorgendorfer K, Marahiel MA. 2002. Functional characterization of 4'-phosphopantetheinyl transferase genes of bacterial and fungal origin by complementation of Saccharomyces cerevisiae lys5. FEMS Microbiol Lett 213:51-57.
43. Moser B, Loetscher P. 2001. Lymphocyte traffic control by chemokines. Nat Immunol 2:123-128.
44. Nakayama T, Fujisawa R, Izawa D, Hieshima K, Takada K, Yoshie O. 2002. Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5. J Virol 76:3072-3077.
45. Nath PR, Dong G, Braiman A, Isakov N. 2014. Immunophilins control T lymphocyte adhesion and migration by regulating CrkII binding to C3G. J Immunol 193:3966-3977.
46. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, Thelen M. 2010. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5:e9175.
47. Nguyen DH, Giri B, Collins G, Taub DD. 2005. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304:559-569.
48. Nguyen DH, Taub D. 2002. CXCR4 function requires membrane cholesterol: Implications for HIV infection. J Immunol 168:4121-4126.
49. Nguyen DH, Taub DD. 2003. Inhibition of chemokine receptor function by membrane cholesterol oxidation. Exp Cell Res 291:36-45.
50. Panchuk R, Skorokhyd N, Chumak V, Lehka L, Omelyanchik S, Gurinovich V, Moiseenok A, Heffeter P, Berger W, Stoika R. 2014. Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: In vitro and in vivo study. Croat Med J 55:206-217.
51. Penet MF, Abou-Hamdan M, Coltel N, Cornille E, Grau GE, de Reggi M, Gharib B. 2008. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc Natl Acad Sci USA 105:1321-1326.
52. Popik W, Alce TM, Au WC. 2002. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol 76:4709-4722.
53. Prisco D, Rogasi PG, Matucci M, Paniccia R, Abbate R, Gensini GF, Neri Serneri GG. 1987. Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia. Angiology 38:241-247.
54. Rana A, Seinen E, Siudeja K, Muntendam R, Srinivasan B, van der Want JJ, Hayflick S, Reijngoud DJ, Kayser O, Sibon OC. 2010. Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc Natl Acad Sci USA 107:6988-6993.
55. Ranganathan S, Jackson RL, Harmony JA. 1982. Effect of pantethine on the biosynthesis of cholesterol in human skin fibroblasts. Atherosclerosis 44:261-273.
56. Resh MD. 1999. Fatty acylation of proteins: New insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1451:1-16.
57. Resh MD. 2006. Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE 2006:14.
58. Rock CO, Calder RB, Karim MA, Jackowski S. 2000. Pantothenate kinase regulation of the intracellular concentration of coenzyme A. J Biol Chem 275:1377-1383.
59. Saccani A, Saccani S, Orlando S, Sironi M, Bernasconi S, Ghezzi P, Mantovani A, Sica A. 2000. Redox regulation of chemokine receptor expression. Proc Natl Acad Sci USA 97:2761-2766.
60. Sallusto F, Lanzavecchia A. 2000. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 177:134-140.
61. Schroeder RJ, Ahmed SN, Zhu Y, London E, Brown DA. 1998. Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains. J Biol Chem 273:1150-1157.
62. Simons K, Toomre D. 2000. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31-39.
63. Stulnig TM, Huber J, Leitinger N, Imre EM, Angelisova P, Nowotny P, Waldhausl W. 2001. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem 276:37335-37340.
64. Van Laethem F, Liang X, Andris F, Urbain J, Vandenbranden M, Ruysschaert JM, Resh MD, Stulnig TM, Leo O. 2003. Glucocorticoids alter the lipid and protein composition of membrane rafts of a murine T cell hybridoma. J Immunol 170:2932-2939.
65. Wange RL. 2000. LAT, the linker for activation of T cells: A bridge between T cell-specific and general signaling pathways. Sci STKE 2000:re1.
66. Xavier R, Brennan T, Li Q, McCormack C, Seed B. 1998. Membrane compartmentation is required for efficient T cell activation. Immunity 8:723-732.
67. Zeyda M, Staffler G, Horejsi V, Waldhausl W, Stulnig TM. 2002. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids. J Biol Chem 277:28418-28423.
68. Zhang W, Trible RP, Samelson LE. 1998. LAT palmitoylation: Its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9:239-246.
69. Zhou H, Tai HH. 2000. Expression and functional characterization of mutant human CXCR4 in insect cells: Role of cysteinyl and negatively charged residues in ligand binding. Arch Biochem Biophys 373:211-217.
70. Zidovetzki R, Levitan I. 2007. Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochim Biophys Acta 1768:1311-1324.
71. Zlotnik A, Yoshie O. 2000. Chemokines: A new classification system and their role in immunity. Immunity 12:121-127.